Clonality, activated antigen-specific CD8(+) T cells, and development of autoimmune cholangitis in dnTGFβRII mice.

Clonality, activated antigen-specific CD8(+) T cells, and development of autoimmune cholangitis in dnTGFβRII mice.
复制标题

DOI:
10.1002/hep.26418
复制
发表时间:
2013-09
期刊:
影响因子:
13.5
通讯作者:
Gershwin, M. Eric
Gershwin, M. Eric
中科院分区:
医学1区
文献类型:
--
作者:
Kawata, Kazuhito;Yang, Guo-Xiang;Ando, Yugo;Tanaka, Hajime;Zhang, Weici;Kobayashi, Yoshimasa;Tsuneyama, Koichi;Leung, Patrick S. C.;Lian, Zhe-Xiong;Ridgway, William M.;Ansari, Aftab A.;He, Xiao-Song;Gershwin, M. Eric

文献摘要

参考文献

被引文献

相似文献

有几种小鼠模型被描述具有与人类原发性胆汁性肝硬化(PBC)相似的特征。在这些模型中,具有与PBC最接近的血清学特征的是具有显性负性转化生长因子β受体II(dnTGFβRII)的T细胞限制性表达的小鼠。我们的工作已经证明来自dnTGFβRII小鼠的CD 8 + T细胞将自身免疫性胆管炎转移到Rag 1-/-受体。然而,尚不清楚自身免疫性胆管炎是否继发于CD 8 + T细胞内的内在功能或由于产生CD 8 + T细胞的异常TGFβR环境。为了解决这一机制问题,我们利用了我们的dnTGFβRII、OT-I/Rag 1-/-、OT-II/Rag 1-/-小鼠,并另外产生了OT-I/dnTGF β RII/Rag 1-/-和OT-II/dnTGFβRII/Rag 1-/-小鼠,其中整个T细胞库分别被卵清蛋白(OVA)特异性CD 8+或CD 4 + T细胞取代。重要的是,亲代OT-I/dnTGFβRII/Rag 1-/-小鼠和/或OT-II/dnTGFβRII/Rag 1-/-小鼠均未发生胆管炎。然而,过继转移证明,只有来自dnTGFβRII小鼠的CD 8 + T细胞的转移,而不是来自OT-I/Rag -/-小鼠或来自OT-I/dnTGFβRII/Rag 1-/-小鼠的CD 8 + T细胞的转移。这些数据并非继发于缺乏CD 4 + T细胞帮助,因为来自OT-I/dnTGFβRII/Rag 1-/-的CD 8 + T细胞和来自OT II/dnTGFβRII/Rag 1-/-的CD 4 + T细胞或来自OT-I/dnTGFβRII/Rag 1-/-的CD 8 + T细胞与来自OT-II/Rag 1-/-小鼠的CD 4 + T细胞的组合未能转移疾病。总之,除了靶向胆管细胞的克隆性CD 8 + T细胞外,有缺陷的TGFβRII信号传导是诱导自身免疫性胆管炎所必需的。
There are several murine models described with features similar to human primary biliary cirrhosis (PBC). Amongst these models, the one which has the closest serologic features to PBC is a mouse with a T cell-restricted expression of the dominant negative transforming growth factor β receptor type II (dnTGFβRII). Our work has demonstrated that CD8+ T cells from dnTGFβRII mice transfer autoimmune cholangitis to Rag1-/- recipients. However, it remained unclear whether the autoimmune cholangitis was secondary to an intrinsic function within CD8+ T cells or due to the abnormal TGFβR environment within which CD8+ T cells were generated. To address this mechanistic issue, we utilized our dnTGFβRII, OT-I/Rag1-/-, OT-II/Rag1-/- mice and in addition generated OT-I/dnTGFβRII/Rag1-/-, and OT-II/dnTGFβRII/Rag1-/- mice in which the entire T cell repertoire was replaced with ovalbumin (OVA) specific CD8+ or CD4+ T cells, respectively. Importantly, neither the parental OT-I/dnTGFβRII/Rag1-/- mice and/or OT-II/dnTGFβRII/Rag1-/- mice developed cholangitis. However, adoptive transfer demonstrated that only transfer of CD8+ T cells from dnTGFβRII mice but not CD8+ T cells from OT-I/Rag -/- mice or from OT-I/dnTGFβRII/Rag1-/- mice transferred disease. These data were not secondary to absence of CD4+ T cell help since a combination of CD8+ T cells from OT-I/dnTGFβRII/Rag1-/- and CD4+ T cells from OT II/dnTGFβRII/Rag1-/- or CD8+ T cells from OT-I/dnTGFβRII/Rag1-/- with CD4+ T cells from OT-II/Rag1-/- mice failed to transfer disease. In conclusion, defective TGFβRII signaling, in addition to clonal CD8+ T cells that target biliary cells, are required for induction of autoimmune cholangitis.
HLA DRB4 0101丙酮酸丙酮酸脱氢酶复合物的限制性免疫主导T细胞自动tip虫中胆汁肝硬化:人体自身免疫性疾病中分子模仿的证据。
DOI: 10.1084/jem.181.5.1835
发表时间: 1995-05-01
期刊: The Journal of experimental medicine
影响因子: --
作者:
Shimoda S;Nakamura M;Ishibashi H;Hayashida K;Niho Y
通讯作者: Niho Y
DOI: 10.1002/hep.22736
发表时间: 2009-03
期刊: HEPATOLOGY
影响因子: 13.5
作者:
Lleo, Ana;Selmi, Carlo;Invernizzi, Pietro;Podda, Mauro;Coppel, Ross L.;Maclay, Ian R.;Gores, Gregory J.;Ansari, Aftab A.;de Water, Judy Van;Gershwin, M. Eric
通讯作者: Gershwin, M. Eric
DOI: 10.1002/hep.25803
发表时间: 2012-10
期刊: HEPATOLOGY
影响因子: 13.5
作者:
Ando, Yugo;Yang, Guo-Xiang;Tsuda, Masanobu;Kawata, Kazuhito;Zhang, Weici;Nakajima, Takahiko;Tsuneyama, Koichi;Leung, Patrick;Lian, Zhe-Xiong;Okazaki, Kazuichi;Ridgway, William M.;Norman, Gary L.;Ansari, Aftab A.;He, Xiao-Song;Coppel, Ross L.;Gershwin, M. Eric
通讯作者: Gershwin, M. Eric
DOI: 10.2353/ajpath.2006.050875
发表时间: 2006-04-01
影响因子: 6
作者:
Polakos, NK;Cornejo, JC;Pierce, RH
通讯作者: Pierce, RH
DOI: 10.1016/s1074-7613(00)80170-3
发表时间: 2000-02-01
期刊: IMMUNITY
影响因子: 32.4
作者:
Gorelik, L;Flavell, RA
通讯作者: Flavell, RA